InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Saturday, 03/19/2022 2:55:29 AM

Saturday, March 19, 2022 2:55:29 AM

Post# of 40501
DNA Vaccine Therapy, INO-8000, INO-9012, EP in Treating Patients With Chronic Hepatitis C Virus Infection
Last Update Submitted that
Met QC Criteria: August 12, 2021 => March 17, 2022
https://clinicaltrials.gov/ct2/history/NCT02772003?A=24&B=25&C=merged#StudyPageTop
Sponsor:
National Cancer Institute (NCI)
Collaborator:
Inovio Pharmaceuticals
P30CA015083 ( U.S. NIH Grant/Contract )
https://reporter.nih.gov/search/yZ8pzDooUk-SQPkyNbxTZQ/projects
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News